NXGL
What one share of Nexgel holds
Surgical and Medical Instruments and Apparatus
We manufacture high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound
Nexgel’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.46 |
|---|---|
| Profit | −$0.75 |
| Cash and investments | $0.18 |
| Debt | $0.06 |
| Book value | $0.51 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | $0.44 | −$0.38 | — | −$0.31 | — | — |
| 2019 | $0.05 | −$0.14 | $0.00 | −$0.13 | — | — |
| 2020 | $0.30 | −$1.05 | $0.14 | −$0.94 | — | $0.03 |
| 2021 | $0.52 | −$1.45 | $0.09 | −$1.01 | — | $2.17 |
| 2022 | $0.37 | −$0.85 | $0.02 | −$0.55 | — | $1.37 |
| 2023 | $0.72 | −$0.56 | $0.12 | −$0.69 | — | $0.82 |
| 2024 | $1.33 | −$0.50 | $0.07 | −$0.66 | — | $0.75 |
| 2025 | $1.45 | −$0.38 | $0.01 | −$0.18 | — | $0.53 |